EPS for Oncolytics Biotech Inc. (ONC) Expected At $-0.03; Ultra Electronics Holdings plc (LON:ULE) Had 7 Bullish Analysts

July 17, 2017 - By Richard Conner

Among 12 analysts covering Ultra Electronics Holdings PLC (LON:ULE), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Ultra Electronics Holdings PLC had 83 analyst reports since July 29, 2015 according to SRatingsIntel. Liberum Capital maintained Ultra Electronics Holdings plc (LON:ULE) on Monday, March 6 with “Buy” rating. The company was maintained on Tuesday, August 2 by JP Morgan. The firm has “Buy” rating by Liberum Capital given on Wednesday, November 11. The stock of Ultra Electronics Holdings plc (LON:ULE) earned “Hold” rating by Deutsche Bank on Friday, June 24. The stock of Ultra Electronics Holdings plc (LON:ULE) has “Buy” rating given on Friday, August 5 by Canaccord Genuity. On Monday, October 10 the stock rating was maintained by JP Morgan with “Overweight”. As per Friday, January 20, the company rating was upgraded by Liberum Capital. Deutsche Bank maintained the shares of ULE in report on Thursday, February 11 with “Hold” rating. The stock of Ultra Electronics Holdings plc (LON:ULE) has “Overweight” rating given on Wednesday, September 14 by JP Morgan. The stock of Ultra Electronics Holdings plc (LON:ULE) earned “Overweight” rating by JP Morgan on Wednesday, December 7. See Ultra Electronics Holdings plc (LON:ULE) latest ratings:

07/07/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 2300.00 New Target: GBX 2300.00 Maintain
07/07/2017 Broker: Deutsche Bank Rating: Hold Old Target: GBX 2050.00 New Target: GBX 2050.00 Maintain
05/07/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 2350.00 New Target: GBX 2400.00 Maintain
27/06/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 2350.00 New Target: GBX 2350.00 Maintain
22/06/2017 Broker: Investec Rating: Buy Old Target: GBX 2300.00 New Target: GBX 2300.00 Maintain
22/06/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 2300.00 New Target: GBX 2300.00 Maintain
22/05/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 2300.00 New Target: GBX 2300.00 Maintain
18/05/2017 Broker: Deutsche Bank Rating: Hold Old Target: GBX 2100.00 New Target: GBX 2050.00 Maintain
28/04/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 2300.00 New Target: GBX 2300.00 Maintain
21/04/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 2350.00 New Target: GBX 2350.00 Maintain

Analysts expect Oncolytics Biotech Inc. (TSE:ONC) to report $-0.03 EPS on August, 3.They anticipate $0.01 EPS change or 50.00% from last quarter’s $-0.02 EPS. After having $-0.03 EPS previously, Oncolytics Biotech Inc.’s analysts see 0.00% EPS growth. About 36,874 shares traded. Oncolytics Biotech Inc. (TSE:ONC) has 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Oncolytics Biotech Inc. is a development-stage company. The company has market cap of $68.23 million. The Firm is focused on the development of REOLYSIN, its cancer therapeutic. It currently has negative earnings. The Company’s clinical program is made up of a registration program that includes muscle-invasive bladder cancer and glioma cancer, over six randomized Phase II clinical trials and approximately six other investigative clinical trials.

Among 3 analysts covering Oncolytics Biotech Inc. (TSE:ONC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Oncolytics Biotech Inc. had 6 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Thursday, November 3 with “Outperform”.

Ultra Electronics Holdings plc provides solutions and products in the defense and aerospace, security and cyber, transport and energy markets, by applying electronic and software technologies. The company has market cap of 1.60 billion GBP. The Firm operates in three divisions: Aerospace & Infrastructure, Communications & Security, and Maritime & Land. It has a 24.85 P/E ratio. The Company’s market facing divisions are Aerospace, Infrastructure, Nuclear, Communications, C2ISR, Maritime, Land and Underwater Warfare.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.